Patent Assignment
Reel/Frame 052544/0327
Assignment of Assignor's Interest
Recorded: 2020-05-01
Pages: 6
Assignor
ORSENIX HOLDINGS BV
Executed: 2020-04-28
Assignee
ORSENIX, LLC
200 ASHFORD CENTER NORTH, SUITE 210, ATLANTA, GEORGIA, 30338
Covered Properties
(4)
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
Application:
16/852,758 →
Publication:
US 2021/0069115
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 20, 2017
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 043636/0641 →
Assignment of Assignor's Interest
Mar 6, 2019
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 048515/0921 →
Assignment of Assignor's Interest
Apr 9, 2019
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 048827/0862 →
Assignment of Assignor's Interest
May 19, 2020
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 052696/0884 →
Assignment of Assignor's Interest
Jan 27, 2021
From: ORSENIX, LLC
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 055044/0652 →
Security Interest
Dec 5, 2024
From: SYROS PHARMACEUTICALS, INC.; TYME TECHNOLOGIES, INC.; TYME INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 069516/0338 →
Release and Reassignment, in Part, of Intellectual Property Security Agreement
Feb 18, 2025
From: OXFORD FINANCE LLC
To: SYROS PHARMACEUTICALS, INC.; TYME TECHNOLOGIES, INC.; TYME, INC.
Reel/Frame 070241/0806 →
Assignment of Assignor's Interest
Mar 19, 2025
From: SYROS PHARMACEUTICALS, INC.
To: QUETZAL THERAPEUTICS, LLC
Reel/Frame 070554/0243 →